# LynxCare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lynxcare

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.lynx.care
- Total disclosed funding: $21M
- Latest round: Series A (Jun 21, 2022)
- Investors on record: 5

## About

LynxCare, Inc. specializes in healthcare data analytics, providing a robust infrastructure that enhances clinical insights for medical professionals through validated real-world data derived from electronic health records.Founded in 2015, LynxCare, Inc. operates out of San Francisco, US, focusing on enhancing healthcare data analytics. The company has executed 7 deals, with the most recent funding round being a Series A on June 21, 2022, led by MTIP, which raised EUR 20.000 mn. Dries Hens and Georges De Feu founded the company, with Georges De Feu currently serving as the CEO.LynxCare provides a scalable real-world data infrastructure primarily focused on enhancing healthcare data analytics and insights. Their core offerings utilize electronic health record (EHR)-derived insights, enabling healthcare professionals to gain high-quality, validated precision medical data. The company has established a federated hospital network that curates and enriches datasets through natural language processing (NLP), facilitating multicenter real-world evidence (RWE) studies. LynxCare serves a diverse clientele, including hospitals and research institutions across Europe, tackling various healthcare challenges such as oncology, mental health, and chronic diseases. The data solutions are designed to be deployable on any cloud platform or on-premise, addressing the needs of clients in markets such as Belgium, Germany, and the broader European Union.LynxCare's revenue structure is primarily based on subscription-based partnerships with healthcare institutions and research entities. Clients access their data analytics services through tailored agreements, which may involve annual subscriptions for ongoing data insights or project-based arrangements for specific studies. The pricing plans are structured around the complexity and scale of the data services provided, including the use of their flagship NLP pipelines and multicenter study capabilities. Transactions typically involve direct engagement with healthcare organizations that require precise, validated data to inform clinical decision-making and research initiatives. As a result, LynxCare builds long-term relationships with its clients, ensuring a steady revenue flow through these partnership agreements.Following its Series A funding round in June 2022, where LynxCare raised EUR 20.000 mn, the company plans to enhance clinical insights for medical professionals. The funding will be utilized to support the development of new products aimed at improving healthcare data analytics and expand into additional markets across Europe. Specific target regions for expansion are currently under consideration as the company seeks to solidify its presence beyond its existing client base.

## Funding rounds

- Series A, Jun 21, 2022, $21M — Elaia Partners, PMV, b2venture, MTIP, HERAN Partners

## Investors

- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Series A
- PMV (https://capitalatlas.ai/funds/pmv) — Series A
- b2venture (https://capitalatlas.ai/funds/b2venture) — Series A
- MTIP (https://capitalatlas.ai/funds/mtip) — Series A
- HERAN Partners (https://capitalatlas.ai/funds/heran-partners) — Series A